|Jeffrey S. Hoch, PhD, Director
Dr. Hoch received his PhD in health economics from the Johns Hopkins Bloomberg School of Public Health. Dr. Hoch also holds a Masters in Economics from the Johns Hopkins University and a Bachelor of Arts degree in Quantitative Economics and Decision Sciences from the University of California at San Diego. Dr. Hoch has taught Health Economics and Economic Evaluation classes in Canada and internationally. Currently, he is pursuing research on the statistical methodology and application of health economics. Special interests include health services research related to mental health and other health issues affecting poor and vulnerable populations. Dr. Hoch is the recipient of a Career Scientist Award from the Ontario Ministry of Health and Long Term Care. Click here for more details.
|Jaclyn Beca, MSc, Manager
Jaclyn completed her BSc (Honours) in biology and her MSc in Health Services Research at the University of Toronto at the Institute for Health Policy, Management and Evaluation. As Manager of the Pharmacoeconomics Research Unit, she works closely with policy-makers, clinicians and researchers to develop and evaluate pharmacoeconomic analyses for new cancer therapies. Her research interests include economic evaluation of cancer screening and treatment interventions, the role of pharmacoeconomic evidence in reimbursement decision-making, and KTE for health economic methods and findings.
|Wanrudee Isaranuwatchai, PhD, Health Economist
Dr. Wanrudee Isaranuwatchai received her PhD in Health Services Research from the Institute of Health Policy, Management and Evaluation at the University of Toronto. She holds a Bachelor of Science in Health Studies and Gerontology from the University of Waterloo. Dr. Isaranuwatchai has experience conducting economic evaluations using decision modeling and person-level data. She is committed to promoting the use of evidence in health care decision making.
|Jean Yong, MASc, Manager
Jean completed her training in operational research and health economics at University of Toronto. For her masters thesis, she applied operational research technique to help hospital decision makers optimize resource allocation in a surgical setting. Prior to joining this unit, she was an analyst at i3 Innovus, where she worked on health economic and outcomes research projects to inform drug reimbursement decisions. Her research interest focuses on optimizing healthcare resource allocation. In particular, she is interested to understand how evidence can help make better healthcare resource allocation decisions.
|Sandjar Djalalov, PhD, Health Economist/Research Fellow
Dr. Djalalov received his PhD in economics from the Institute of Macroeconomics and Social Studies in Tashkent, Uzbekistan. Dr. Djalalov also holds a Masters in agricultural economics from the Council of Study of Productive Forces and a Bachelor of Engineering degree from Tashkent Irrigation Institute. His research interest includes development of pharmacoeconomics models, systematic reviews and meta-analysis. He has conducted economic evaluations in pharmacogenomics of Alzheimer disease, lung and breast cancers and meta-analysis of colorectal cancer utilities. Area of his interest includes dissemination of HTA knowledge in developing countries.
|Dilfuza Djalalova, PhD, Research Assistant
Dilfuza received her PhD and Master of Arts from the Tashkent State University of Pedagogy in Uzbekistan. She is studying the use of an ICER threshold in health sector decision making and use of net- benefit analysis in economic evaluations. She is specializing in conducting systematic reviews and literature search. Her interest includes development of training materials for teaching HTA in transition economies.
|Rebecca Mercer, PhD, Network Manager, Canadian Centre for Applied Research in Cancer Control (ARCC)
Rebecca received her PhD in Medical Genetics from the University of Alberta in 2012. She also holds a BSc in Biomedical Sciences from the University of Guelph. Rebecca previously worked with the Canadian Obesity Network, which developed her keen interest in health policy development, network building, and knowledge translation and dissemination. Rebecca is also interested in the genetic basis of cancer and the development of personalized medicine.